Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey.
Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey.
复制标题
DOI：
10.1371/journal.pone.0110412
复制
发表时间：
2014
期刊：
影响因子：
3.7
通讯作者：
Jun JK
中科院分区：
文献类型：
--
作者：
Shin JY;Shim HY;Jun JK
这项研究旨在确定和比较韩国人群中癌症幸存者和两个非癌症对照组中糖尿病意识、治疗和适当血糖控制的普及率，这些对照组包括没有癌症病史但有其他慢性病(非癌症、慢性病对照)的个人和没有癌症或任何其他慢性病病史(非癌症、非慢性病对照)的个人。我们分析了参加2007年至2011年韩国国家健康与营养检查调查的2,660名糖尿病患者(年龄30岁)的数据。意识被定义为被临床医生诊断为糖尿病的对象。治疗被定义为服用抗糖尿病药物的受试者。适当的血糖控制被定义为血红蛋白A1c水平为7%。多变量Logistic回归和预测边际被用来评估癌症幸存者和两个非癌症对照组之间的意识、治疗或适当的血糖控制是否有所不同。癌症幸存者的知晓率高于非癌症、慢性病和非癌症、非慢性病对照组(分别为85.1%、80.4%和60.4%)。虽然幸存者接受治疗和适当的血糖控制的比例高于非癌症、非慢性病对照组，但低于非癌症、慢性病对照组。癌症幸存者接受糖尿病治疗的比例为67.5%，非癌症、慢性病对照组为69.5%，非癌症、非慢性病对照组为46.7%，血糖控制良好的比例分别为31.7%、34.6%和17.8%。与非癌症慢性病受试者相比，癌症幸存者接受糖尿病治疗和达到适当的血糖目标的可能性较小。需要特别关注和教育，以确保这一人群得到最佳的糖尿病护理，并需要确定初级保健和专科医生的系统作用。
This study aimed to determine and compare the prevalences of diabetes awareness, treatment, and adequate glycemic control among cancer survivors in a Korean population and two non-cancer control groups, comprising individuals without a history of cancer but with other chronic diseases (non-cancer, chronic disease controls) and individuals without a history of cancer or any other chronic disease (non-cancer, non-chronic disease controls). We analyzed data from 2,660 subjects with prevalent diabetes (aged ≥30 years), who had participated in the 2007–2011 Korea National Health and Nutrition Examination Survey. Awareness was defined as a subject having been diagnosed with diabetes by a clinician. Treatment was defined as a subject who was taking anti-diabetic medicine. Adequate glycemic control was defined as a hemoglobin A1c level of <7%. Multivariable logistic regression and predictive margins were used to evaluate whether awareness, treatment, or adequate glycemic control differed among cancer survivors and the two non-cancer control groups. Cancer survivors had greater awareness compared with the non-cancer, chronic disease and non-cancer, non-chronic disease control groups (85.1%, 80.4%, and 60.4%, respectively). Although the prevalences of treatment and adequate glycemic control were higher for survivors compared with the non-cancer, non-chronic disease controls, they were lower compared with the non-cancer, chronic disease controls. The prevalence of diabetes treatment was 67.5% for cancer survivors, 69.5% for non-cancer, chronic disease controls, and 46.7% for non-cancer, non-chronic disease controls; the prevalences of adequate glycemic control in these three groups were 31.7%, 34.6%, and 17.8%, respectively. Cancer survivors were less likely than the non-cancer chronic disease subjects to receive diabetes management and to achieve adequate glycemic targets. Special attention and education are required to ensure that this population receives optimal diabetes care, and the systematic roles for primary care and specialist physicians need to be determined.
登录
查看更多内容
影响因子：
16.2
作者：
Hoerger, Thomas J.;Gregg, Edward W.;Saaddine, Jinan B.
通讯作者：
Saaddine, Jinan B.
影响因子：
5
作者：
Coughlin, SS;Calle, EE;Thun, MJ
通讯作者：
Thun, MJ
影响因子：
16.2
作者：
Bjornholt, JV;Erikssen, G;Thaulow, E
通讯作者：
Thaulow, E
影响因子：
10.3
作者：
Hu, FB;Manson, JE;Giovannucci, E
通讯作者：
Giovannucci, E
影响因子：
3.7
作者：
Byun, Sang-Ho;Ma, Seung Hyun;Park, Boyoung
通讯作者：
Park, Boyoung